Ramzy I et al. |
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. |
2016 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:27982354
|
Gbinigie II and Lasserson D |
Clarithromycin-induced akathisia: a class effect of macrolides? |
2016 |
BMJ Case Rep |
pmid:27927708
|
Kasai C et al. |
Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. |
2016 |
BMC Gastroenterol |
pmid:27716077
|
Gisbert JP |
Helicobacter pylori-related diseases. |
2016 |
Gastroenterol Hepatol |
pmid:27888863
|
Noda H et al. |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori. |
2016 |
J Gastrointestin Liver Dis |
pmid:27689190
|
Giorgio F et al. |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. |
2016 |
Scand. J. Gastroenterol. |
pmid:27687850
|
Donzelli A |
Helicobacter pylori Eradication? |
2016 |
Gastroenterology |
pmid:27590693
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Bonfigli AR et al. |
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. |
2016 |
Nutr Metab Cardiovasc Dis |
pmid:27480449
|
Orrin E et al. |
Sporotrichoid Mycobacterium chelonae. |
2016 |
Australas. J. Dermatol. |
pmid:27469486
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Ferro BE et al. |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27458221
|
Patton PH et al. |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease. |
2016 |
Cochrane Database Syst Rev |
pmid:27444319
|
Christl I et al. |
Clarithromycin and Tetracycline Binding to Soil Humic Acid in the Absence and Presence of Calcium. |
2016 |
Environ. Sci. Technol. |
pmid:27438991
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Sakurai Y et al. |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study. |
2016 |
Adv Ther |
pmid:27432383
|
Inagaki K et al. |
Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum. |
2016 |
Intern. Med. |
pmid:27432106
|
Hirasawa K et al. |
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. |
2016 |
PLoS ONE |
pmid:27977675
|
Mougari F et al. |
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27690688
|
Kuo CH et al. |
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice. |
2016 |
Medicine (Baltimore) |
pmid:27227911
|
Sluch IM et al. |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection. |
2016 |
Cornea |
pmid:27227391
|
Laird-Fick HS et al. |
Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. |
2016 |
Postgrad Med J |
pmid:27222587
|
Phiphatpatthamaamphan K et al. |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:27221874
|
Kim SY et al. |
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. |
2016 |
BMC Infect. Dis. |
pmid:27188784
|
Suzuki S et al. |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. |
2016 |
Am. J. Gastroenterol. |
pmid:27185079
|
Xu J et al. |
Preparation, characterization and pharmacokinetics evaluation of clarithromycin-loaded Eudragit(®) L-100 microspheres. |
2016 |
Eur J Drug Metab Pharmacokinet |
pmid:25652786
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Buchicchio A et al. |
Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography - high-resolution tandem mass spectrometry (FTICR MS-IRMPD). |
2016 |
Sci. Total Environ. |
pmid:27039063
|
Melia MT and Auwaerter PG |
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. |
2016 |
N. Engl. J. Med. |
pmid:27028918
|
Berende A et al. |
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. |
2016 |
N. Engl. J. Med. |
pmid:27028911
|
D'Erme AM et al. |
Successful treatment of rosacea fulminans in a 59-year-old woman with macrolide antibiotics and prednisone. |
2016 |
Int. J. Dermatol. |
pmid:27028670
|
Klesiewicz K et al. |
Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. |
2016 |
J. Antibiot. |
pmid:27025351
|
Kawashima K et al. |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy. |
2016 |
Dig Liver Dis |
pmid:27012448
|
Ormeci A et al. |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27010145
|
Dubini M et al. |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin. |
2016 |
Ann. Allergy Asthma Immunol. |
pmid:27009438
|
Belz D et al. |
Mycobacterium marinum infection initially diagnosed as metastatic Crohn's disease. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25510444
|
Niv Y |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis. |
2016 |
Digestion |
pmid:26849820
|
Song Z et al. |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. |
2016 |
Dig Liver Dis |
pmid:26847964
|
Vannarath S et al. |
Antibiotic Resistant Pattern of Helicobacter Pylori Infection Based on Molecular Tests in Laos. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:26838225
|
Miyamoto S et al. |
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples. |
2016 |
Tumour Biol. |
pmid:26825980
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Gaüzère BA and Malvy D |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015]. |
2016 |
Bull Soc Pathol Exot |
pmid:26818816
|
Topp E et al. |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field. |
2016 |
Sci. Total Environ. |
pmid:27096634
|
Li X et al. |
Macrolides use and the risk of sudden cardiac death. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27086751
|
Konstantinidis T et al. |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643338
|
Ferro BE et al. |
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643335
|
Boyanova L et al. |
Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains. |
2016 |
Microb. Drug Resist. |
pmid:26618567
|
Wu TS et al. |
Postcesarean section wound infection caused by Mycobacterium massiliense. |
2016 |
J Microbiol Immunol Infect |
pmid:26350122
|
Senatore FJ et al. |
Helicobacter pylori treatment: Still a work in progress. |
2016 |
Postgrad Med |
pmid:26490697
|
Shin WG et al. |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey. |
2016 |
Helicobacter |
pmid:26470999
|
Cerqueira RM et al. |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery? |
2016 |
Obes Surg |
pmid:26467690
|
Boyanova L et al. |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria. |
2016 |
Infect Dis (Lond) |
pmid:26465202
|
Narita M et al. |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. |
2016 |
Bull. Tokyo Dent. Coll. |
pmid:27665691
|
Ghaith D et al. |
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt. |
2016 |
J Chemother |
pmid:26358218
|
Yoon H et al. |
Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial. |
2016 |
Gut Liver |
pmid:26347514
|
Liou JM et al. |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of in the community and hospital populations: a randomised trial. |
2016 |
Gut |
pmid:26338825
|
Sun W et al. |
Synergistic drug combination effectively blocks Ebola virus infection. |
2017 |
Antiviral Res. |
pmid:27890675
|
Hung IFN et al. |
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial. |
2017 |
Chest |
pmid:27884765
|
Ustundag GH et al. |
The Effects of Synbiotic " B94 plus Inulin" Addition on Standard Triple Therapy of Eradication in Children. |
2017 |
Can J Gastroenterol Hepatol |
pmid:28656129
|
Peng X et al. |
Gastric Juice-Based Real-Time PCR for Tailored Treatment: A Practical Approach. |
2017 |
Int J Med Sci |
pmid:28638276
|
Ozturk O et al. |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication. |
2017 |
Arab J Gastroenterol |
pmid:28601610
|
Aguilera-Correa JJ et al. |
Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. |
2017 |
Diagn. Microbiol. Infect. Dis. |
pmid:27863951
|
Alirezaei A et al. |
Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients. |
2017 |
Iran J Kidney Dis |
pmid:28575885
|
Katayama Y et al. |
Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation. |
2017 |
Life Sci. |
pmid:27825902
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Moj D et al. |
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens. |
2017 |
AAPS J |
pmid:27822600
|
Angol DC et al. |
from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. |
2017 |
Biomed Res Int |
pmid:28555193
|
Akpinar Z et al. |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth. |
2017 |
Arab J Gastroenterol |
pmid:28532623
|
Beckman E et al. |
A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. |
2017 |
J. Clin. Microbiol. |
pmid:28515219
|
Ivanová L et al. |
Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka. |
2017 |
Environ. Res. |
pmid:28183039
|
Varma MV et al. |
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast. |
2017 |
Clin. Pharmacol. Ther. |
pmid:27648490
|
Huet D et al. |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. |
2017 |
Rev Mal Respir |
pmid:27639948
|
El Haj C et al. |
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance? |
2017 |
Med. Microbiol. Immunol. |
pmid:27639707
|
Jia L et al. |
Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28711353
|
Seyama S et al. |
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A). |
2017 |
J. Antimicrob. Chemother. |
pmid:27999037
|
Zerbetto De Palma G et al. |
Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City. |
2017 |
Microb. Drug Resist. |
pmid:27391421
|
Legendre T et al. |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy]. |
2017 |
Encephale |
pmid:27178256
|
Choi HS et al. |
Peritoneal Dialysis-Related Peritonitis Caused by Microbacterium paraoxydans. |
2017 |
Jpn. J. Infect. Dis. |
pmid:27169951
|
Serrano CA et al. |
Helicobacter pylori-Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country. |
2017 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:27159208
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Laidler N |
Cutaneous infection with paucibacillary treated successfully with a modified antituberculous drug regimen. |
2017 |
BMJ Case Rep |
pmid:29275384
|
Chen MJ et al. |
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961996
|
Kim SY et al. |
Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea. |
2017 |
Helicobacter |
pmid:28940815
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Tsay FW et al. |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807915
|
Koratala A et al. |
Exit Site Infection in Peritoneal Dialysis; Need for Follow-Up on Cultures Despite Clinical Improvement. |
2017 |
Blood Purif. |
pmid:28268216
|
Lin CM et al. |
Is ionizing radiation a risk factor to diffuse panbronchiolitis? |
2017 |
QJM |
pmid:28069906
|
Jung YS et al. |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776746
|
Makihara K et al. |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients. |
2017 |
Cancer Chemother. Pharmacol. |
pmid:28711984
|
Tanabe H et al. |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature. |
2017 |
Dig. Dis. Sci. |
pmid:28664410
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Sue S et al. |
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication. |
2017 |
Intern. Med. |
pmid:28566587
|
Hu Y et al. |
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance. |
2017 |
Front Cell Infect Microbiol |
pmid:28529929
|
Su J et al. |
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial. |
2017 |
Medicine (Baltimore) |
pmid:28207505
|
Branquinho D et al. |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics? |
2017 |
BMC Gastroenterol |
pmid:28202013
|
Inukai K et al. |
Effect of gel formation on the dissolution behavior of clarithromycin tablets. |
2017 |
Int J Pharm |
pmid:28196716
|
Miftahussurur M et al. |
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic. |
2017 |
Am. J. Trop. Med. Hyg. |
pmid:28193745
|
Zhang Z et al. |
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. |
2017 |
Int. J. Antimicrob. Agents |
pmid:28188830
|
Kristin F et al. |
Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin. |
2017 |
Eur J Pharm Sci |
pmid:28179133
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|